10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2020 | |||
Consolidated Statement of Cash Flows | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 19, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Cash Flow From (Used in) Operating Activities: | |||
| Net earnings | $ 4,495 | 3,687 | 2,368 |
| Adjustments to reconcile earnings to net cash from operating activities - | |||
| Depreciation | 1,195 | 1,078 | 1,100 |
| Amortization of intangible assets | 2,132 | 1,936 | 2,178 |
| Share-based compensation | 546 | 519 | 477 |
| Amortization of inventory step-up | 32 | ||
| Investing and financing losses, net | 425 | 184 | 126 |
| Loss on extinguishment of debt | 63 | 167 | |
| Trade receivables | (924) | (275) | (190) |
| Inventories | (493) | (593) | (514) |
| Prepaid expenses and other assets | (627) | (138) | 23 |
| Trade accounts payable and other liabilities | 1,766 | 220 | 747 |
| Income taxes | (614) | (545) | (214) |
| Net Cash From Operating Activities | 7,901 | 6,136 | 6,300 |
| Cash Flow From (Used in) Investing Activities: | |||
| Acquisitions of property and equipment | (2,177) | (1,638) | (1,394) |
| Acquisitions of businesses and technologies, net of cash acquired | (42) | (170) | (54) |
| Proceeds from business dispositions | 58 | 48 | 48 |
| Purchases of investment securities | (83) | (103) | (131) |
| Proceeds from sales of investment securities | 10 | 21 | 73 |
| Other | 19 | 27 | 102 |
| Net Cash From (Used in) Investing Activities | (2,215) | (1,815) | (1,356) |
| Cash Flow From (Used in) Financing Activities: | |||
| Proceeds from issuance of (repayments of) short-term debt, net and other | 2 | (26) | |
| Proceeds from issuance of long-term debt and debt with maturities over 3 months | 1,281 | 1,842 | 4,009 |
| Repayments of long-term debt and debt with maturities over 3 months | (1,333) | (3,441) | (12,433) |
| Purchases of common shares | (403) | (718) | (238) |
| Proceeds from stock options exercised | 245 | 298 | 271 |
| Dividends paid | (2,560) | (2,270) | (1,974) |
| Other | (11) | ||
| Net Cash From (Used in) Financing Activities | (2,779) | (4,289) | (10,391) |
| Effect of exchange rate changes on cash and cash equivalents | 71 | (16) | (116) |
| Net Increase (Decrease) in Cash and Cash Equivalents | 2,978 | 16 | (5,563) |
| Cash and Cash Equivalents, Beginning of Year | 3,860 | 3,844 | |
| Cash and Cash Equivalents, End of Year | 6,838 | 3,860 | 3,844 |
| Supplemental Cash Flow Information: | |||
| Income taxes paid | 970 | 930 | 740 |
| Interest paid | 549 | 677 | 845 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |